Back

Virological characteristics of the SARS-CoV-2 XBB.1.5 variant

Tamura, T.; Irie, T.; Deguchi, S.; Yajima, H.; Tsuda, M.; Nasser, H.; Mizuma, K.; Plianchaisuk, A.; Suzuki, S.; Uriu, K.; Begum, M. M.; Shimizu, R.; Jonathan, M.; Suzuki, R.; Kondo, T.; Ito, H.; Kamiyama, A.; Yoshimatsu, K.; Shofa, M.; Hashimoto, R.; Anraku, Y.; Kimura, K. T.; Kita, S.; Sasaki, J.; Sasaki-Tabata, K.; Maenaka, K.; Nao, N.; Wang, L.; Oda, Y.; The Genotype to Phenotype Japan (G2P-Japan) Consortium, ; Ikeda, T.; Saito, A.; Matsuno, K.; Ito, J.; Tanaka, S.; Sato, K.; Hashiguchi, T.; Takayama, K.; Fukuhara, T.

2023-08-17 microbiology
10.1101/2023.08.16.553332 bioRxiv
Show abstract

Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB.1.5 evolved from XBB.1 by acquiring the F486P spike (S) mutation, subsequent to the acquisition of a nonsense mutation in ORF8. Neutralization assays showed similar abilities of immune escape between XBB.1.5 and XBB.1. We determined the structural basis for the interaction between human ACE2 and the S protein of XBB.1.5, showing similar overall structures between the S proteins of XBB.1 and XBB.1.5. The intrinsic pathogenicity of XBB.1.5 in hamsters is lower than that of XBB.1. Importantly, we found that the ORF8 nonsense mutation of XBB.1.5 resulted in impairment of MHC expression. In vivo experiments using recombinant viruses revealed that the XBB.1.5 mutations are involved with reduced virulence of XBB.1.5. Together, these data suggest that the mutations in ORF8 and S could enhance spreading of XBB.1.5 in humans.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.